Maria Mar Hernandez Guillamon Senior Researcher, Neurovascular Research Lab, VHIR. Institutions of which they are part Main researcher Neurovascular Diseases Vall Hebron Institut de Recerca Twitter Email Maria Mar Hernandez Guillamon Twitter Email Institutions of which they are part Main researcher Neurovascular Diseases Vall Hebron Institut de Recerca Senior Researcher, Neurovascular Research Lab, VHIR.
Dr. Mar Hernández-Guillamon has dedicated her career to the study of cerebral amyloid angiopathy (CAA) and other pathologies associated with the deposition of amyloid-beta (Abeta). In 2013, she was awarded by Carlos III Spanish Health Institute with the Miguel Servet contract to establish the Cerebral Amyloidosis line of research at VHIR. Her group has positioned in forefront of the Abeta-pathologies field, studying the molecular mechanisms involved in the Abeta transport and metabolism using in vitro and in vivo models. Her lab has also dedicated to the clinical research and discovery of biomarkers associated with CAA and other cerebrovascular diseases. The translational research developed by Dr. Hernandez-Guillamon's group has allowed the achievement of important aims to date, as demonstrated by the scientific production obtained (h-index= 35, 80 publications, >3700 citations) and the continuous leadership of national and international projects.
Projects Sol·licitud de la Dra. Mar Hernández dels contractes Miguel Servet II IP: Joan Montaner Villalonga Collaborators: Maria Mar Hernandez Guillamon, Laia Perez Lasarte Funding agency: Instituto de Salud Carlos III Funding: 101250 Reference: CPII17/00010 Duration: 01/01/2018 - 31/12/2020 Therapeutic effect of rApoA-I-Milano in an AD model IP: Maria Mar Hernandez Guillamon Collaborators: Anna Penalba Morenilla Funding agency: BrightFocus Foundation Funding: 254465.28 Reference: RAPOA-I-MILANO_BRIGTHFOCUSF2017 Duration: 01/07/2017 - 30/06/2021 Incorporació Dr. Joan Montaner a la RETICS en Malalties vasculars cerebrals (ICTUS) IP: - Collaborators: Anna Rosell Novel, Mercedes Arrue Gonzalo, Bustamante Rangel, Alejandro, Marcel Lamana Vallverdu, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Maria Pilar Delgado Martínez, Guillem Colell Dinares, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel Funding agency: Instituto de Salud Carlos III Funding: 240669 Reference: RD16/0019/0021 Duration: 01/01/2017 - 31/12/2021 Interplay of amyloid and ischemia and their influence on blood-brain barrier, amyloid transportation systems and neurodegeneration in cerebral amyloid angiopathy (CAA) IP: Maria Mar Hernandez Guillamon Collaborators: - Funding agency: Instituto de Salud Carlos III Funding: 65340 Reference: AC15/00030 Duration: 01/01/2016 - 30/11/2020 Pagination First page « Previous page ‹ … Page 2 Page 3 Current page 4 Page 5 Page 6 … Next page › Last page »
